Bausch Health

Forecast & Rating7 analysts currently cover Bausch Health, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $7.50, about 29.3% upside from the current price of $5.80. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 35.5% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Bausch Health's outlook. Data as of Sep 30, 2026; for reference only and not investment advice.